Viewing StudyNCT00064974



Ignite Creation Date: 2024-05-05 @ 11:31 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00064974
Status: COMPLETED
Last Update Posted: 2013-04-04
First Post: 2003-07-16

Brief Title: Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes
Sponsor: Celgene Corporation
Organization: Celgene

Conditions & Keywords Data

Conditions:
Name
Myelodysplastic Syndromes
Keywords:
Name View
Celgene View
MDS View
CC-5013 View
Revlimid View